Toho Holdings Co., Ltd. (8129.T)
JPY 4661.0
(-0.53%)
JPY 4661.0
(-0.53%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -98.42 Billion JPY | -103.73% |
| 2022 | -48.31 Billion JPY | 9.73% |
| 2021 | -53.51 Billion JPY | -8.81% |
| 2020 | -49.18 Billion JPY | -24.59% |
| 2019 | -39.47 Billion JPY | 5.45% |
| 2018 | -41.75 Billion JPY | -2.38% |
| 2017 | -40.78 Billion JPY | -917.24% |
| 2016 | -4 Billion JPY | -221.23% |
| 2015 | 3.3 Billion JPY | 169.0% |
| 2014 | -4.79 Billion JPY | -129.33% |
| 2013 | 16.34 Billion JPY | 192.2% |
| 2012 | -17.72 Billion JPY | -68.21% |
| 2011 | -10.53 Billion JPY | -350.55% |
| 2010 | 4.2 Billion JPY | -55.99% |
| 2009 | 9.55 Billion JPY | 263.38% |
| 2008 | 2.63 Billion JPY | 1298.94% |
| 2007 | 188 Million JPY | 100.68% |
| 2006 | -27.45 Billion JPY | -123.93% |
| 2005 | -12.25 Billion JPY | -187.3% |
| 2004 | -4.26 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -104.75 Billion JPY | -6.43% |
| 2023 Q2 | -100.82 Billion JPY | -83.15% |
| 2023 Q3 | -92.53 Billion JPY | 8.22% |
| 2023 Q4 | -98.42 Billion JPY | -6.37% |
| 2023 Q1 | -55.05 Billion JPY | -13.95% |
| 2023 FY | -98.42 Billion JPY | -103.73% |
| 2022 Q2 | -64.47 Billion JPY | -15.34% |
| 2022 FY | -48.31 Billion JPY | 9.73% |
| 2022 Q4 | -48.31 Billion JPY | 36.38% |
| 2022 Q1 | -55.89 Billion JPY | -4.45% |
| 2022 Q3 | -75.93 Billion JPY | -17.78% |
| 2021 Q3 | -70.81 Billion JPY | -16.58% |
| 2021 Q1 | -59.06 Billion JPY | -20.09% |
| 2021 Q2 | -60.74 Billion JPY | -2.84% |
| 2021 FY | -53.51 Billion JPY | -8.81% |
| 2021 Q4 | -53.51 Billion JPY | 24.42% |
| 2020 Q2 | -47.56 Billion JPY | -2.83% |
| 2020 Q1 | -46.25 Billion JPY | -17.18% |
| 2020 FY | -49.18 Billion JPY | -24.59% |
| 2020 Q4 | -49.18 Billion JPY | 9.72% |
| 2020 Q3 | -54.48 Billion JPY | -14.54% |
| 2019 Q4 | -39.47 Billion JPY | 33.0% |
| 2019 FY | -39.47 Billion JPY | 5.45% |
| 2019 Q3 | -58.91 Billion JPY | -84.55% |
| 2019 Q1 | -44.94 Billion JPY | -7.65% |
| 2019 Q2 | -31.92 Billion JPY | 28.98% |
| 2018 Q3 | -43.14 Billion JPY | 9.91% |
| 2018 Q4 | -41.75 Billion JPY | 3.22% |
| 2018 Q2 | -47.88 Billion JPY | -16.98% |
| 2018 Q1 | -40.93 Billion JPY | -0.38% |
| 2018 FY | -41.75 Billion JPY | -2.38% |
| 2017 Q3 | -38.14 Billion JPY | 6.49% |
| 2017 Q2 | -40.79 Billion JPY | -117.53% |
| 2017 Q1 | -18.75 Billion JPY | -367.75% |
| 2017 FY | -40.78 Billion JPY | -917.24% |
| 2017 Q4 | -40.78 Billion JPY | -6.92% |
| 2016 Q4 | -4 Billion JPY | 90.19% |
| 2016 Q3 | -40.87 Billion JPY | -151.49% |
| 2016 FY | -4 Billion JPY | -221.23% |
| 2016 Q2 | -16.25 Billion JPY | 28.44% |
| 2016 Q1 | -22.71 Billion JPY | -786.76% |
| 2015 FY | 3.3 Billion JPY | 169.0% |
| 2015 Q1 | -6.8 Billion JPY | -41.87% |
| 2015 Q2 | -5.97 Billion JPY | 12.09% |
| 2015 Q3 | -31.18 Billion JPY | -421.6% |
| 2015 Q4 | 3.3 Billion JPY | 110.61% |
| 2014 Q4 | -4.79 Billion JPY | 83.03% |
| 2014 FY | -4.79 Billion JPY | -129.33% |
| 2014 Q1 | -3.08 Billion JPY | -118.87% |
| 2014 Q3 | -28.24 Billion JPY | -637.72% |
| 2014 Q2 | -3.82 Billion JPY | -24.12% |
| 2013 FY | 16.34 Billion JPY | 192.2% |
| 2013 Q2 | 3.53 Billion JPY | 124.97% |
| 2013 Q1 | -14.15 Billion JPY | 20.17% |
| 2013 Q3 | -9.04 Billion JPY | -356.07% |
| 2013 Q4 | 16.34 Billion JPY | 280.65% |
| 2012 Q3 | -14.45 Billion JPY | 12.31% |
| 2012 Q1 | -22.3 Billion JPY | -111.66% |
| 2012 Q2 | -16.47 Billion JPY | 26.12% |
| 2012 FY | -17.72 Billion JPY | -68.21% |
| 2012 Q4 | -17.72 Billion JPY | -22.67% |
| 2011 Q4 | -10.53 Billion JPY | -53.48% |
| 2011 Q3 | -6.86 Billion JPY | -157.76% |
| 2011 FY | -10.53 Billion JPY | -350.55% |
| 2011 Q2 | 11.88 Billion JPY | 2456.56% |
| 2011 Q1 | 465 Million JPY | -88.94% |
| 2010 Q3 | -6.01 Billion JPY | -238.51% |
| 2010 Q1 | -10.38 Billion JPY | -208.67% |
| 2010 Q2 | 4.34 Billion JPY | 141.81% |
| 2010 FY | 4.2 Billion JPY | -55.99% |
| 2010 Q4 | 4.2 Billion JPY | 169.94% |
| 2009 Q2 | 10.96 Billion JPY | 0.0% |
| 2009 FY | 9.55 Billion JPY | 263.38% |
| 2009 Q3 | -9.04 Billion JPY | -182.45% |
| 2009 Q4 | 9.55 Billion JPY | 205.68% |
| 2008 Q4 | 2.63 Billion JPY | 196.66% |
| 2008 FY | 2.63 Billion JPY | 1298.94% |
| 2008 Q3 | -2.72 Billion JPY | 0.0% |
| 2007 FY | 188 Million JPY | 100.68% |
| 2006 FY | -27.45 Billion JPY | -123.93% |
| 2005 FY | -12.25 Billion JPY | -187.3% |
| 2004 FY | -4.26 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 8135.02% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 102.244% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 125.249% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 71.591% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | -2661.665% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | -133.488% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | -60.115% |
| Eisai Co., Ltd. | -97.93 Billion JPY | -0.507% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | -14656.972% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | -89.94% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | -198.985% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 1394.778% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 1364.992% |
| Tsumura & Co. | 1.61 Billion JPY | 6194.675% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | -122.892% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | -185.823% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 156.992% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 469.7% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 439.624% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 1494.178% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | 14081.392% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 1742.674% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | -1410.341% |
| MedRx Co., Ltd | -1.72 Billion JPY | -5622.616% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | -1029.231% |
| Solasia Pharma K.K. | -668 Million JPY | -14634.88% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | -6591.585% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | -1257.08% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 274.143% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | -3224.436% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | -784.39% |